Hospital Profile
Name | Multicare Good Samaritan Hospital |
---|
Type | Acute Care Hospital |
---|
Location | 401 15th Avenue Se, Puyallup, Washington |
---|
Ownership | Voluntary non-profit - Private |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 500079 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Multicare Good Samaritan Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1841231461 |
Organization Name | MULTICARE HEALTH SYSTEM |
Doing Business As | MULTICARE GOOD SAMARITAN HOSPITAL |
Address | 401 15th Ave Se, Puyallup, WA 98372 |
Hospital Type | General Acute Care Hospital |
Phone Number | 253-697-4000 |
News Archive
Survey reveals impact of health care law on seniors
A survey of 460 seniors 65 and older revealed that 70% believe the Patient Protection and Affordable Care Act will reduce their Medicare benefits, despite the fact that the bill does not cut Medicare benefits and instead adds some, including a yearly free checkup and other free preventive care services.
Modern military helmets no better at blast wave protection than historical designs
Biomedical engineers from Duke University have demonstrated that, despite significant advancements in protection from ballistics and blunt impacts, modern military helmets are no better at protecting the brain from shock waves created by nearby blasts than their World War I counterparts.
Shifting toward novel pricing models that closely link drug's price to its value
One of the health care issues about which seemingly all Americans agree: Prescription drug prices have skyrocketed. And they keep going higher.
Osteros Biomedica initiates MBC-11 phase 1 study in patients with cancer-induced bone disease
Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation of Russian Venture Company announced today that the first cohort of patients has been dosed in a phase 1 study of its drug MBC-11 in patients with cancer-induced bone disease.
Read more Medical News
› Verified 4 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Survey reveals impact of health care law on seniors
A survey of 460 seniors 65 and older revealed that 70% believe the Patient Protection and Affordable Care Act will reduce their Medicare benefits, despite the fact that the bill does not cut Medicare benefits and instead adds some, including a yearly free checkup and other free preventive care services.
Modern military helmets no better at blast wave protection than historical designs
Biomedical engineers from Duke University have demonstrated that, despite significant advancements in protection from ballistics and blunt impacts, modern military helmets are no better at protecting the brain from shock waves created by nearby blasts than their World War I counterparts.
Shifting toward novel pricing models that closely link drug's price to its value
One of the health care issues about which seemingly all Americans agree: Prescription drug prices have skyrocketed. And they keep going higher.
Osteros Biomedica initiates MBC-11 phase 1 study in patients with cancer-induced bone disease
Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation of Russian Venture Company announced today that the first cohort of patients has been dosed in a phase 1 study of its drug MBC-11 in patients with cancer-induced bone disease.
Read more News
› Verified 4 days ago